The pathophysiology of mitochondrial disease as modeled in the mouse
- PMID: 19651984
- PMCID: PMC2720256
- DOI: 10.1101/gad.1784909
The pathophysiology of mitochondrial disease as modeled in the mouse
Abstract
It is now clear that mitochondrial defects are associated with a plethora of clinical phenotypes in man and mouse. This is the result of the mitochondria's central role in energy production, reactive oxygen species (ROS) biology, and apoptosis, and because the mitochondrial genome consists of roughly 1500 genes distributed across the maternal mitochondrial DNA (mtDNA) and the Mendelian nuclear DNA (nDNA). While numerous pathogenic mutations in both mtDNA and nDNA mitochondrial genes have been identified in the past 21 years, the causal role of mitochondrial dysfunction in the common metabolic and degenerative diseases, cancer, and aging is still debated. However, the development of mice harboring mitochondrial gene mutations is permitting demonstration of the direct cause-and-effect relationship between mitochondrial dysfunction and disease. Mutations in nDNA-encoded mitochondrial genes involved in energy metabolism, antioxidant defenses, apoptosis via the mitochondrial permeability transition pore (mtPTP), mitochondrial fusion, and mtDNA biogenesis have already demonstrated the phenotypic importance of mitochondrial defects. These studies are being expanded by the recent development of procedures for introducing mtDNA mutations into the mouse. These studies are providing direct proof that mtDNA mutations are sufficient by themselves to generate major clinical phenotypes. As more different mtDNA types and mtDNA gene mutations are introduced into various mouse nDNA backgrounds, the potential functional role of mtDNA variation in permitting humans and mammals to adapt to different environments and in determining their predisposition to a wide array of diseases should be definitively demonstrated.
Similar articles
-
The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement.Gene. 2005 Jul 18;354:169-80. doi: 10.1016/j.gene.2005.05.001. Gene. 2005. PMID: 16024186 Review.
-
Mitochondrial DNA mutations in disease and aging.Environ Mol Mutagen. 2010 Jun;51(5):440-50. doi: 10.1002/em.20586. Environ Mol Mutagen. 2010. PMID: 20544884 Review.
-
Animal models for mitochondrial disease.Methods Mol Biol. 2002;197:3-54. doi: 10.1385/1-59259-284-8:003. Methods Mol Biol. 2002. PMID: 12013805 Review.
-
A mitochondrial paradigm for degenerative diseases and ageing.Novartis Found Symp. 2001;235:247-63; discussion 263-6. doi: 10.1002/0470868694.ch20. Novartis Found Symp. 2001. PMID: 11280029 Review.
-
Mouse models for mitochondrial disease.Am J Med Genet. 2001 Spring;106(1):71-93. doi: 10.1002/ajmg.1393. Am J Med Genet. 2001. PMID: 11579427 Review.
Cited by
-
Hypoxia-mediated rescue of retinal ganglion cells deficient in mitochondrial complex I is independent of the hypoxia-inducible factor pathway.Sci Rep. 2024 Oct 15;14(1):24114. doi: 10.1038/s41598-024-75916-x. Sci Rep. 2024. PMID: 39406814 Free PMC article.
-
Redox regulation in lifespan determination.J Biol Chem. 2024 Mar;300(3):105761. doi: 10.1016/j.jbc.2024.105761. Epub 2024 Feb 15. J Biol Chem. 2024. PMID: 38367668 Free PMC article. Review.
-
Treatment of a patient with severe lactic acidosis and multiple organ failure due to mitochondrial myopathy: A case report.World J Clin Cases. 2023 Aug 6;11(22):5398-5406. doi: 10.12998/wjcc.v11.i22.5398. World J Clin Cases. 2023. PMID: 37621593 Free PMC article.
-
Continuous Hypoxia Reduces Retinal Ganglion Cell Degeneration in a Mouse Model of Mitochondrial Optic Neuropathy.Invest Ophthalmol Vis Sci. 2022 Dec 1;63(13):21. doi: 10.1167/iovs.63.13.21. Invest Ophthalmol Vis Sci. 2022. PMID: 36538003 Free PMC article.
-
Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes.EMBO Mol Med. 2021 Dec 7;13(12):e14397. doi: 10.15252/emmm.202114397. Epub 2021 Nov 8. EMBO Mol Med. 2021. PMID: 34750991 Free PMC article.
References
-
- Acin-Perez R, Bayona-Bafaluy MP, Bueno M, Machicado C, Fernandez-Silva P, Perez-Martos A, Montoya J, Lopez-Perez MJ, Sancho J, Enriquez JA. An intragenic suppressor in the cytochrome c oxidase I gene of mouse mitochondrial DNA. Hum Mol Genet. 2003;12:329–339. - PubMed
-
- Agostino A, Invernizzi F, Tiveron C, Fagiolari G, Prelle A, Lamantea E, Giavazzi A, Battaglia G, Tatangelo L, Tiranti V, et al. Constitutive knockout of Surf1 is associated with high embryonic lethality, mitochondrial disease and cytochrome c oxidase deficiency in mice. Hum Mol Genet. 2003;12:399–413. - PubMed
-
- Alavi MV, Bette S, Schimpf S, Schuettauf F, Schraermeyer U, Wehrl HF, Ruttiger L, Beck SC, Tonagel F, Pichler BJ, et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain. 2007;130:1029–1042. - PubMed
-
- Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–465. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous